MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Welcure Drugs and Pharmaceuticals - BSE: 524661, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Welcure Drugs and Pharmaceuticals
Welcure Drugs and Pharmaceuticals
BSE: 524661|ISIN: INE331C01017|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 15, 17:00
1.64
0
VOLUME 11
Welcure Drugs and Pharmaceuticals is not listed on NSE
« Mar 11
Notes to Accounts Year End : Mar '12
1 Contingent Liability
 
 There is no claim against the Company, which is to be acknowledged as
 debt.
 
 2.  Realized value of current assets
 
 In the opinion of the Board and to the best of the knowledge and
 belief, the value on realization of current assets in the ordinary
 course of business will not be less than the amount at which they are
 stated in Balance Sheet.
 
 3.  Foreign Exchange
 
 Earning in foreign exchange during the year was Nil (Previous Year
 Nil). Also, there is no expenditure in foreign exchange during the year
 (Previous Year Nil).
 
 4.  Segment Reporting
 
 During the year, the Company has not entered into business activities.
 Hence, the requirement of segment reporting as per Accounting Standard
 17 issued by the Institute of Chartered Accountants of India (ICAI) is
 not applicable.
 
 5.  Provision of benefits for employees
 
 In the previous year, due to closure of factory at Bhiwadi; most of the
 employees left the Company gradually. A provision of Rs. 34,00,000/-
 towards gratuity and leave encashment for the remaining workers/staff
 was made at the end of the previous year. Out of the said provision, an
 amount of Rs.  2,86,395/- has been paid to the staff of the Company and
 Rs. 13,00,000/- payable to one of the directors has been shown as
 liability in the books of accounts on full & final settlement of such
 staff & director. The remaining excess provision of Rs. 18,13,605/- has
 been written off under the head other income as the same is no longer
 required in the view of the management of the Company.
 
 6.  Prior period Items
 
 Prior period expenses amounting to Rs. 16,153/-(Previous Year Rs.
 6200/-) mainly on account of personnel and other expenses, have been
 accounted for under the relevant heads of account.
 
 7.  Previous year figures have been regrouped/ rearranged wherever
 considered necessary for comparison and to compliance with provisions of
 revised schedule VI of the Companies Act, 1956.
Source : Dion Global Solutions Limited
Quick Links for welcuredrugspharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.